| OARSI guidelines for the non-surgical management of knee osteoarthritis TE McAlindon, RR Bannuru, MC Sullivan, NK Arden, F Berenbaum, ... Osteoarthritis and cartilage 22 (3), 363-388, 2014 | 3840 | 2014 |
| Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial JY Reginster, R Deroisy, LC Rovati, RL Lee, E Lejeune, O Bruyere, ... The Lancet 357 (9252), 251-256, 2001 | 2132 | 2001 |
| The role of reactive oxygen species in homeostasis and degradation of cartilage YE Henrotin, P Bruckner, JPL Pujol Osteoarthritis and cartilage 11 (10), 747-755, 2003 | 904 | 2003 |
| OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis F Dobson, RS Hinman, EM Roos, JH Abbott, P Stratford, AM Davis, ... Osteoarthritis and cartilage 21 (8), 1042-1052, 2013 | 872 | 2013 |
| European guidelines for prevention in low back pain: November 2004 AK Burton, F Balagué, G Cardon, HR Eriksen, Y Henrotin, A Lahad, ... European Spine Journal 15 (Suppl 2), s136, 2006 | 810 | 2006 |
| Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis F Richy, O Bruyere, O Ethgen, M Cucherat, Y Henrotin, JY Reginster Archives of Internal Medicine 163 (13), 1514-1522, 2003 | 735 | 2003 |
| Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Y Henrotin, B Kurz, T Aigner Osteoarthritis and cartilage 13 (8), 643-654, 2005 | 596 | 2005 |
| Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis VB Kraus, B Burnett, J Coindreau, S Cottrell, D Eyre, M Gendreau, ... Osteoarthritis and Cartilage 19 (5), 515-542, 2011 | 362 | 2011 |
| Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib MC Hochberg, J Martel-Pelletier, J Monfort, I Möller, JR Castillo, N Arden, ... Annals of the rheumatic diseases 75 (1), 37-44, 2016 | 325 | 2016 |
| The minor collagens in articular cartilage Y Luo, D Sinkeviciute, Y He, M Karsdal, Y Henrotin, A Mobasheri, ... Protein & cell 8 (8), 560-572, 2017 | 254 | 2017 |
| Biological actions of curcumin on articular chondrocytes Y Henrotin, AL Clutterbuck, D Allaway, EM Lodwig, P Harris, ... Osteoarthritis and cartilage 18 (2), 141-149, 2010 | 242 | 2010 |
| Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis Y Henrotin, R Raman, P Richette, H Bard, J Jerosch, T Conrozier, ... Seminars in arthritis and rheumatism 45 (2), 140-149, 2015 | 238 | 2015 |
| What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Y Henrotin, M Marty, A Mobasheri Maturitas 78 (3), 184-187, 2014 | 232 | 2014 |
| OARSI clinical trials recommendations: design, conduct, and reporting of clinical trials for knee osteoarthritis TE McAlindon, JB Driban, Y Henrotin, DJ Hunter, GL Jiang, ST Skou, ... Osteoarthritis and cartilage 23 (5), 747-760, 2015 | 230 | 2015 |
| Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis T Appelboom, J Schuermans, G Verbruggen, Y Henrotin, JY Reginster Scandinavian journal of rheumatology 30 (4), 242-247, 2001 | 227 | 2001 |
| Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes C Sanchez, MA Deberg, N Piccardi, P Msika, JYL Reginster, YE Henrotin Osteoarthritis and cartilage 13 (11), 988-997, 2005 | 226 | 2005 |
| Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management Y Henrotin, F Priem, A Mobasheri Springerplus 2, 1-9, 2013 | 225 | 2013 |
| Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial Y Panahi, N Khalili, E Sahebi, S Namazi, LE Simental-Mendía, M Majeed, ... Drug research 68 (07), 403-409, 2018 | 218 | 2018 |
| Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6,-1β … C Sanchez, MA Deberg, N Piccardi, P Msika, JYL Reginster, YE Henrotin Osteoarthritis and cartilage 13 (11), 979-987, 2005 | 217 | 2005 |
| Nutraceuticals: do they represent a new era in the management of osteoarthritis?–a narrative review from the lessons taken with five products Y Henrotin, C Lambert, D Couchourel, C Ripoll, E Chiotelli Osteoarthritis and Cartilage 19 (1), 1-21, 2011 | 213 | 2011 |
Christelle Sanchezdental Biomaterials Research Unit, University of Liège, BelgiumVerified email at uliege.be
